Multiple cellular and tissue targets

The term "multiple cellular and tissue targets" refers to drug targets, mechanisms, or pathological processes that engage numerous molecular components across different cell types and tissues rather than a single defined entity. This category is often used in the context of network pharmacology, immuno-oncology, or disease research where the therapeutic effect, pathogenesis, or biomarker is distributed across cellular networks, multicellular modules, or tissue-level structural units[1][2]. Recent approaches in multiplex imaging and omics have identified that coordination among various cells (such as immune cells, fibroblasts, endothelial cells) defines tissue function and disease states, often forming multicellular modules or neighborhoods[1][2]. These are not single molecular entities but higher-order arrangements identified through spatial mapping and systems biology, and may inform future drug development strategies that target not isolated molecules but these entire networks or modules[1][2]. In summary, "multiple cellular and tissue targets" is too broad and non-specific to be mapped to any canonical molecular target; it describes systems-level targeting rather than an actionable druggable entity. This entry is better replaced or disambiguated with the names of the specific molecules, receptors, or pathways involved if that information is available.

Other names

Multicellular modulesCross-tissue targetsMulticellular ecosystemsTissue networksCellular neighborhoods